Close Menu

genomics

Institute Director Eric Green noted that a lack of diversity in the scientific and clinical workforce has negative consequences for how research is conducted.

The researchers said that the virus' genome can be classified in six major types, which are characterized by 14 signature single nucleotide variations.

Eric Green, NHGRI director

Green and his NHGRI colleagues published a strategic vision for human genomics research, emphasizing data science, implementation of genomics, and human diversity.

As part of the strategy paper, the institute also compiled a list of 10 bold predictions for human genomics that might come true by 2030.

Reveal Genomics plans to have assays available within three years, and is eager to partner with pharmaceutical and diagnostics companies to fulfill its vision.

The latest group includes several firm developing genomics tools or diagnostics, but COVID-19 is preventing them from accessing their lab space for the time being.

The funding comes about three years after Amgen provided the school with $1.5 million for a master's degree program in human genetics and genetic counseling.

Accredited by the same group behind MP3 audio, the new genomics standard promises more efficient data handling, but fans of GA4GH file formats are pushing back.

The program, launched last year, is designed to help early-career investigators who have primarily worked within groups pursuing independent research.

Investigators saw signs that risky TP53 missense mutations may interfere with wild type copies of the tumor suppressor gene in acute myeloid leukemia and other myeloid cancers.

Pages

Imperial College London researchers are shifting away from testing a COVID-19 vaccine to focus on combating newly emerging SARS-CoV-2 variants, the Independent says.

According to the Associated Press, genetic genealogy has helped law enforcement officials identify an unknown victim of the Green River Killer.

In PNAS this week: target to reduce chemotherapy-induced cardiac injury, tool finds ancient endogenous RNA viruses, and more.

Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.